Gold nanoshells (NSs) have already shown great promise as photothermal actuators for cancer therapy. Integrin ?v?3 is a marker that is specifically and preferentially overexpressed on multiple tumor types and on angiogenic tumor neovasculature. Active targeting of NSs to integrin ?v?3 offers the potential to increase accumulation preferentially in tumors and thereby enhance therapy efficacy.